# Clinical Validation of Continuous Glucose Monitoring in Glycemic Management of Critically Ill Sepsis Patients

> **NCT07686939** · — · COMPLETED · sponsor: **Taizhou Hospital** · enrollment: 60 (actual)

## Conditions studied

- Sepsis
- Hyperglycemia
- Glycemic Control

## Interventions

- **DEVICE:** Continuous Glucose Monitoring (CGM) with FreeStyle Libre II System

## Key facts

- **NCT ID:** NCT07686939
- **Lead sponsor:** Taizhou Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07686939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07686939, "Clinical Validation of Continuous Glucose Monitoring in Glycemic Management of Critically Ill Sepsis Patients". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT07686939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*